Antinociceptive effects of interleukin-4, -10, and -13 on the writhing response in mice and zymosan-induced knee joint incapacitation in rats

Journal of Pharmacology and Experimental Therapeutics

Volumn 304, Issue 1, 2003, Pages 102-108

  Vale, Mariana L ^a   Marques, Jaciara B ^a   Moreira, Camila A ^a   Rocha, Francisco Aírton C ^a   Ferreira, Sérgio H ^b   Poole, Stephen ^c   Cunha, Fernando Q ^b   Ribeiro, Ronaldo A ^a  

^a FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 1BETA; INTERLEUKIN 4; NALOXONE; RECOMBINANT PROTEIN; TUMOR NECROSIS FACTOR ALPHA; ZYMOSAN;

ANALGESIC ACTIVITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG EFFECT; HOT PLATE TEST; KNEE PAIN; MALE; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; RAT; WRITHING TEST;

ACETIC ACID; ANALGESICS; ANIMALS; ANTIBODIES, BLOCKING; ARTHRITIS, EXPERIMENTAL; BEHAVIOR, ANIMAL; INTERLEUKIN-1; INTERLEUKIN-10; INTERLEUKIN-13; INTERLEUKIN-4; JOINTS; MALE; MICE; NALOXONE; NARCOTIC ANTAGONISTS; PAIN MEASUREMENT; PERITONEAL CAVITY; RATS; REACTION TIME; TUMOR NECROSIS FACTOR-ALPHA; ZYMOSAN;

EID: 0037215530     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.102.038703     Document Type: Article

References (40)

1. Bogdan C, Vodovotz Y, and Nathan C (1991) Macrophage deactivation by interleukin-10. J Exp Med 174:1549-1555.
2. Burd PR, Thompson WC, Max EE, and Mills FC (1995) Activated mast cells produce interleukin-13. J Exp Med 181:1373-1380.
3. Callard RE, Mattheus DJ, and Hibbert L (1996) IL-4 and IL-13 receptors: Are they one and the same? Immunol Today 17:108-110.
4. Cassatella MA, Meda L, Bonora S, Ceska M, and Constantin G (1993) Interleukin-10 (IL-10) inhibits the release of proinflammatory cytokines from human polymorphonuclear leukocytes. Evidence for an autocrine role of tumor necrosis factor and IL-1β in mediating the production of IL-8 triggered by lipopolysaccharide. J Exp Med 178:2207-2211.
5. Collier HOJ, Dinneen LC, Chistine A, Johnson A, and Schneider C (1968) The abdominal constriction response and its suppression by analgesic drugs in the mouse. Br J Pharmacol Chemother 32:295-310.
6. Cunha FQ, Lorenzetti BB, Poole S, and Ferreira SH (1991) Interleukin-8 as a mediator of sympathetic pain. Br J Pharmacol 104:765-767.
7. Cunha FQ, Moncada S, and Liew FY (1992b) Interleukin-10 (IL-10) inhibits the induction of nitric oxide synthase by interferon-γ in murine macrophages. Biochem Biophys Res Commun 182:1155-1159.
8. Cunha FQ, Poole S, Lorenzetti BB, and Ferreira SH (1992a) The pivotal role of tumor necrosis factor α in the development of inflammatory hyperalgesia. Br J Pharmacol 107:660-664.
9. Cunha FQ, Poole S, Lorenzetti BB, Veiga FH, and Ferreira SH (1999) Cytokine-mediated inflammatory hyperalgesia limited by interleukin-4. Br J Pharmacol 126:45-50.
10. Czlonkowski A, Stein C, and Herz A (1993) Peripheral mechanisms of opioid antinociception in inflammation: Involvement of cytokines. Eur J Pharmacol 242:229-235.
11. De Waal Malefyt R, Abrams J, Bennet B, Figdor C, and Devries JE (1991) Interleukin-10 (IL-10) inhibits cytokine synthesis by human monocytes: An autoregulatory role of IL-10 produced by monocytes. J Exp Med 174:1209-1220.
12. De Waal Malefyt R, Abrams JS, Zurawski SM, Lecron JC, Mohan-Peterson S, Sanjanwala B, Bennett B, Silver J, de Vries JE, and Yssel H (1995) Differential regulation of IL-13 and IL-4 production by human CD8+ and CD4+ Th0, Th1 and Th2 T cell clones and EBV-transformed B cells. Int Immunol Sep 7:1405-1416.
13. Di Santo E, Adami M, Bertorelli R, and Ghezzi P (1997) Systemic interleukin-10 administration inhibits brain tumor necrosis factor production in mice. Eur J Pharmacol 336:197-202.
14. Dinarello CA, Cannon JG, Wolff SM, Bernheim HA, Beutler B, Cerami A, Figari IS, Palladino MA, and O'Connor JV Jr (1986) Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1. J Exp Med 163: 1443-1449.
15. Duarte ID, Nakamura M, and Ferreira SH (1988) Participation of the sympathetic system in acetic acid-induced writhing in mice. Braz J Med Biol Res 21:341-345.
16. Eddy NB and Leimbach D (1953) Synthetic analgesics II. Dithienyl-butenoyl and dithenylbutyllamines. J Pharmacol Exp Ther 107:385-389.
17. Faccioli LH, Souza GE, Cunha FQ, Poole S, and Ferreira SH (1990) Recombinant interleukin-1 and tumor necrosis factor induce neutrophil migration "in vivo" by indirect mechanisms. Agents Actions 30:334-339.
18. Ferreira SH, Lorenzetti BB, Bristow AF, and Poole S (1988) Interleukin-1β as a potent hyperalgesic agent antagonized by a tripeptide analogue. Nature (Lond) 334:698-700.
19. Ferreira SH, Lorenzetti BB, and Poole S (1993) Bradykinin initiates cytokine-mediated inflammatory hyperalgesia. Br J Pharmacol 110:1227-1231.
20. Fiorentino DF, Bond MW, and Mosmann TR (1989) Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J Exp Med 170:2081-2095.
21. Fiorentino DF, Zlotnik A, Mosmann TR, Howard M, and O'Garra A (1991) IL-10 inhibits cytokine production by activated macrophages. J Immunol 147:3815-3822.
22. 2. Proc Natl Acad Sci USA 86:3803-3807.
23. Howard M and O'Garra A (1992) Biological properties of IL-10. Immunology Today 13:198-200.
24. Isomaki P, Luukkainen R, Toivanen P, and Punnonen J (1996) The presence of Interleukin-13 in rheumatoid synovium and its anti-inflammatory effects on synovial fluid macrophages from patients with rheumatoid arthritis. Arthritis Rheum 39:1693-1702.
25. Lorenzetti BB, Poole S, Veiga FH, Cunha FQ, and Ferreira SH (2001) Cytokine-mediated inflammatory hyperalgesia limited by interleukin-13. Eur Cytokine Netw 12:260-267.
26. McKenzie AN, Culpepper JA, de Waal Malefyt R, Briere F, Punnonen J, Aversa G, Sato A, Dang W, Cocks G, Menon S, et al. (1993) Interleukin-13, a T cell derived cytokine that regulates human monocyte and B cell function. Proc Natl Acad Sci USA 90:3735-3739.
27. Muchamuel T, Menon S, Pisacane P, Howard MC, and Cockayne DA (1997) IL-13 protects mice from lipopolysaccharide-induced lethal endotoxemia: Correlation with down-modulation of TNF-α, IFN-γ and IL-2 production. J Immunol 158: 2898-2903.
28. Nakamura M and Ferreira SH (1987) A peripheral sympathetic component in inflammatory hyperalgesia. Eur J Pharmacol 135:145-153.
29. Niiro H, Otsuka T, Izuhara K, Yamaoka K, Ohshima K, Tanabe T, Hara S, Nemoto Y, Tanaka Y, Nakashima H, and Niho Y (1997) Regulation by interleukin-10 and interleukin-4 of cyclooxygenase-2 expression in human neutrophils. Blood 89: 1621-1628,
30. Niiro H, Otsuka T, Tanabe T, Hara S, Kuga S, Nemoto Y, Tanaka Y, Nakashima H, Kitajima S, Abe M, et al. (1995) Inhibition by interleukin-10 of inducible cyclooxygenase expression in lipopolysaccharide-stimulated monocytes: Its underlying mechanism in comparison with IL-4. Blood 85:3736-3745.
31. Onoe Y, Miyaura C, Kaminakayashiki T, Nagai Y, Noguchi K, Chen QR, Seo H, Ohta H, Nozawa S, Kudo I, and Suda T (1996) IL-13 and IL-4 inhibit bone resorption by suppressing cyclooxygenase-2 -dependent prostaglandin synthesis in osteoblasts. J Immunol 156:758-764.
32. Oswald IP, Wynn TA, and Sher A (1992) Interleukin 10 inhibits macrophage microbicidal activity by blocking the endogenous production of tumor necrosis factor-α required as a costimulatory factor for interferon gamma-induced activation. Proc Natl Acad Sci USA 89:8676-8680.
33. Plunkett JA, Yu CG, Easton JM, Bethea JR, and Yezierski RP (2001) Effects of interleukin-10 (IL-10) on pain behavior and gene expression following excitotoxic spinal cord injury in the rat. Exp Neurol Mar 168:144-154.
34. Poole S, Cunha FQ, Selkirk S, Lorenzetti BB, and Ferreira SH (1995) Cytokine-mediated inflammatory hyperalgesia limited by interleukin-10. Br J Pharmacol 115:684-688.
35. Ribeiro RA, Vale ML, Thomazzi SM, Cunha FQ, and Ferreira SH (2000) Involvement of resident macrophages and mast cells in the writhing nociceptive response induced by zymosan and acetic acid in mice. Eur J Pharmacol 387:111-118.
36. Rocha FA, Aragao AG Jr, Oliveira RC, Pompeu MM, Vale MR, and Ribeiro RA (1999) Periarthritis promotes gait disturbance in zymosan-induced arthritis in rats. Inflamm Res 48:485-490.
37. Röcken M, Racke M, and Shevach EM (1996) IL-4-induced immune deviation as antigen-specific therapy for inflammatory autoimmune disease. Immunol Today 17:225-231.
38. Seitz M, Loetscher P, Dewald B, Towbin H, Ceska M, and Baggiolini M (1994) Production of interleukin-1 receptor antagonist, inflammatory chemotactic proteins and prostaglandin E by rheumatoid and osteoarthritic synoviocytes: Regulation by IFN-γ and IL-4. J Immunol 152:2060-2065.
39. Thomazzi SM, Ribeiro RA, Campos DI, Cunha FQ, and Ferreira SH (1997) Tumor necrosis factor, interleukin-1 and interleukin-8 mediate the nociceptive activity of the supernatant of LPS-stimulated macrophages. Mediators of Inflammation 6:195-200.
40. Tonussi CR and Ferreira SH (1992) Rat-knee joint incapacitation test: An objective screen for central and peripheral analgesics. Pain 48:421-427.